Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing daptomycin versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia is currently in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin (daptomycin)
  • Vancomycin (vancomycin)

Snippet

Sponsor: Todd C. Lee MD MPH FIDSA | Conditions: Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia | Phase 4 | Status: RECRUITING